microarray and bioinformatic analyses (Shanghai Genechem Ltd)
90
Structured Review
Shanghai Genechem Ltd
microarray and bioinformatic analyses
Microarray And Bioinformatic Analyses, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+and+bioinformatic+analyses/affymetrix+microarrays/pm31128486-51-2-8
Average 90 stars, based on 1 article reviews
Microarray And Bioinformatic Analyses, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+and+bioinformatic+analyses/affymetrix+microarrays/pm31128486-51-2-8
Average 90 stars, based on 1 article reviews
microarray and bioinformatic analyses - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Microarray:Article Title: Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1. Article Snippet: Background: Triptolide (TPL) can enhance the sensitivity of pancreatic cancer cells to tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL), but available research is limited to whether TPL can affect the relevant downstream signaling pathways of TRAIL.. Current knowledge is far from adequate to fully understand the mechanisms by which TPL increases TRAIL sensitivity of pancreatic cancer.. Purpose: We aimed to find TPL-regulated upstream components of the signaling pathways of TRAIL to further understand the regulatory mechanism by which TPL increases the sensitivity to TRAIL. Comparison:Article Title: Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1. Article Snippet: Background: Triptolide (TPL) can enhance the sensitivity of pancreatic cancer cells to tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL), but available research is limited to whether TPL can affect the relevant downstream signaling pathways of TRAIL.. Current knowledge is far from adequate to fully understand the mechanisms by which TPL increases TRAIL sensitivity of pancreatic cancer.. Purpose: We aimed to find TPL-regulated upstream components of the signaling pathways of TRAIL to further understand the regulatory mechanism by which TPL increases the sensitivity to TRAIL. |